Sherlock Biosciences Announces Two Upcoming December Conferences
Cambridge, Mass., December 2, 2019—Sherlock Biosciences, an Engineering Biology company dedicated to making diagnostic testing better, faster and more affordable, today announced that it will attend the following two conferences in December:
- Evercore ISI HealthCONx Conference 2019: Rahul Dhanda, Sherlock Co-Founder, President and Chief Executive Officer will present a corporate overview on Thursday, Dec. 5 at 8:45 a.m. ET, in Boston, Mass.
- Cell Free Systems Conference 2019: Will Blake, Ph.D., Sherlock Chief Technology Officer, is serving as co-chair of the first U.S. conference on cell-free systems, which will be held Dec. 4 – 6, 2019, at the Hyatt Regency in Boston, Mass.
About Sherlock Biosciences
Sherlock Biosciences is dedicated to making molecular diagnostics better, faster and more affordable through Engineering Biology platforms. The company is developing applications of SHERLOCK™, a CRISPR-based method to detect and quantify specific genetic sequences, and INSPECTRTM, a Synthetic Biology-based molecular diagnostics platform that is instrument free. SHERLOCK and INSPECTR can be used in virtually any setting without complex instrumentation, opening up a wide range of potential applications in areas including precision oncology, infection identification, food safety, at-home tests, and disease detection in the field. For more information visit Sherlock.bio.